‘Medicare discriminates’: RACGP advocates for women’s health The college has given a national committee its feedback on how to tackle discrimination against women in healthcare and reduce inequity in Medicare.
Tailored contraceptive advice key for CALD patients: Study Offering highly targeted and easy-to-understand education is crucial to empowering women to make informed decisions, one GP researcher found.
Mirena lifespan extended to eight years With Australian uptake still relatively low, it is hoped the change will encourage more women to consider the long-acting reversible contraception.
Many pharmacies lacking first-line emergency contraception: Study New research suggests an internationally recognised gold standard emergency contraceptive is only available in 59% of Australian regional pharmacies.
OCP pharmacy pilot announced for WA While the RACGP does not support pharmacy prescribing, its place on the working group is an opportunity to minimise risk.
Study questions Paxlovid’s COVID-19 ‘usefulness’ Researchers say the antiviral does little to reduce symptom duration for some vaccinated patients, but still recommended its use for the vulnerable.
ACT GPs expand free abortion access General practices have been supported to carry out medical terminations at no cost, with experts now calling on other states to follow suit.
Tighten Paxlovid eligibility: PBAC advice The committee that looks at PBS listings has recommended the first-line COVID-19 treatment be limited to the highest risk patients aged 50–69 years.
GPs’ role in early detection of oral cancer now easier A new CPD activity aims to upskill GPs in prevention counselling, early identification and referral pathways for the cancer.
Do NSAIDs increase clot risk in women on the pill? Experts question research that suggests women who use both oral contraceptive and non-steroidal anti-inflammatories may be at greater risk.